BiotechTube
Home/SOPHiA GENETICS/Dr. Pierre Hutter
DP

Dr. Pierre Hutter

Chief Scientific Officer & Co-Founder

SOPHiA GENETICS

Therapeutic Areas

OncologyRare and Inherited Disorders

SOPHiA GENETICS Pipeline

DrugIndicationPhase
SOPHiA DDM™ Dx HRD SolutionHomologous Recombination Deficiency in CancerCommercial
SOPHiA DDM™ Dx Solid Tumor SolutionPan-Cancer Solid Tumor ProfilingCommercial
SOPHiA DDM™ Dx Myeloid SolutionMyeloid Blood CancersCommercial
SOPHiA DDM™ Dx Hereditary Cancer SolutionInherited Cancer RiskCommercial
SOPHiA DDM™ Dx RNAtarget Oncology SolutionGene Fusions & Expression in CancerCommercial
SOPHiA DDM™ for RadiomicsQuantitative Imaging Analysis (e.g., Lung Cancer)Development
SOPHiA DDM™ for MultimodalIntegrated Multi-Omics & Imaging AnalysisR&D
MSK-ACCESS® powered with SOPHiA DDM™Liquid Biopsy for CancerCommercial

Leadership Team at SOPHiA GENETICS

DJ
Dr. Jurgi Camblong
Chief Executive Officer & Co-Founder
RR
Ruth-Anne Renaud
Chief Financial Officer
KP
Kevin Puylaert
Chief Commercial Officer
MC
Miro Civic
Chief Technology Officer
PD
Prof. Dr. med. Peter Bauer
Chief Genomic Officer
View full SOPHiA GENETICS profile